Lakmal Ranathunga

Mr. Lakmal Ranathunga

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Niranjan DodantennaNiranjan Dodantenna
Niranjan Dodantenna
JCJi-Won Cha
Ji-Won Cha
Chathuranga KiramageChathuranga Kiramage
Chathuranga Kiramage
WCW.A.Gayan Chathuranga
W.A.Gayan Chathuranga
Asela WeerawardhanaAsela Weerawardhana
Asela Weerawardhana
JLJong-Soo Lee
Jong-Soo Lee
DP96R of African swine fever virus (ASFV), also known as uridine kinase (UK), encodes a virulence-associated protein. Previous studies have examined DP96R along with other genes in an effort to create live attenuated vaccines. While experiments in pigs have explored the impact of DP96R on the pathogenicity of ASFV, the precise molecular mechanism underlying this phenomenon remains unknown. Here, we describe a novel molecular mechanism by which DP96R suppresses interferon regulator factor-3 (IRF3)-mediated antiviral immune responses. DP96R interacts with a crucial karyopherin (KPNA) binding site within IRF3, disrupting the KPNA-IRF3 interaction and consequently impeding the translocation of IRF3 to the nucleus. Under this mechanistic basis, the ectopic expression of DP96R enhances the replication of DNA and RNA viruses by inhibiting the production of IFNs, whereas DP96R knock-down resulted in higher IFNs and IFN-stimulated gene (ISG) transcription during ASFV infection. Collectively, these findings underscore the pivotal role of DP96R in inhibiting IFN responses and increase our understanding of the relationship between DP96R and the virulence of ASFV.

30 November 2023 in Journal of Virology
Verified
Journal Article
Open access
LRLakmal Ranathunga
Lakmal Ranathunga
NDNiranjan Dodantenna
Niranjan Dodantenna
JCJi-Won Cha
Ji-Won Cha
KCKiramage Chathuranga
Kiramage Chathuranga
WCW. A. Gayan Chathuranga
W. A. Gayan Chathuranga
JLJong-Soo Lee
Jong-Soo Lee
Type I interferon (IFN)-mediated responses operate a pivotal role in the first line of host immune defense against viruses. Upon DNA virus infection, DNA sensing cyclic GMP-AMP synthase-STING signal pathway is a key event in the IFN-mediated antiviral response and also a target of viral immune evasion. African swine fever (ASF) is a highly contagious, cross-border viral disease that often confers fatalities in domestic and feral pigs of all ages. African swine fever virus (ASFV), a causative agent of ASF, is a nucleocytoplasmic large DNA virus that masks critical elements of host immune system by several encoded proteins. In this study, we report a novel immune evasion mechanism of ASFV B175L to block type I IFN signaling by targeting STING and 2'3'-cyclic GMP-AMP (2′3′-cGAMP). We found that ASFV B175L significantly inhibited the DNA virus-induced IFN-β production and IFN-mediated signaling responses. The conserved zf-FCS motif of ASFV B175L competitively interacted with both cGAMP and the cyclic dinucleotide binding domain of STING. Remarkably, the R238 and Y240 amino acids of STING were crucial for interaction with ASFV B175L. Consequently, this interaction inhibits the interaction between cGAMP and STING, thereby inhibiting downstream signaling including STING polymerization and phosphorylation of TANK-binding kinase 1 and interferon regulatory factor 3 for antiviral signaling. Taken together, these results highlight the critical role of ASFV B175L in suppression of IFN responses and provide a new target to guide live-attenuated ASFV vaccine. IMPORTANCE: African swine fever virus (ASFV), the only known DNA arbovirus, is the causative agent of African swine fever (ASF), an acutely contagious disease in pigs. ASF has recently become a crisis in the pig industry in recent years, but there are no commercially available vaccines. Studying the immune evasion mechanisms of ASFV proteins is important for the understanding the pathogenesis of ASFV and essential information for the development of an effective live-attenuated ASFV vaccines. Here, we identified ASFV B175L, previously uncharacterized proteins that inhibit type I interferon signaling by targeting STING and 2′3′-cGAMP. The conserved B175L-zf-FCS motif specifically interacted with both cGAMP and the R238 and Y240 amino acids of STING. Consequently, this interaction interferes with the interaction of cGAMP and STING, thereby inhibiting downstream signaling of IFN-mediated antiviral responses. This novel mechanism of B175L opens a new avenue as one of the ASFV virulent genes that can contribute to the advancement of ASFV live-attenuated vaccines.

25 March 2021 in Viruses
Verified
Journal Article
Open access
PDF file
Chathuranga KiramageChathuranga Kiramage
Chathuranga Kiramage
Asela WeerawardhanaAsela Weerawardhana
Asela Weerawardhana
Niranjan DodantennaNiranjan Dodantenna
Niranjan Dodantenna
LRLakmal Ranathunga
Lakmal Ranathunga
WCWon-Kyung Cho
Won-Kyung Cho
JLJong-Soo Lee
Jong-Soo Lee
Sargassum fusiforme, a plant used as a medicine and food, is regarded as a marine vegetable and health supplement to improve life expectancy. Here, we demonstrate that S. fusiforme extract (SFE) has antiviral effects against respiratory syncytial virus (RSV) in vitro and in vivo mouse model. Treatment of HEp2 cells with a non-cytotoxic concentration of SFE significantly reduced RSV replication, RSV-induced cell death, RSV gene transcription, RSV protein synthesis, and syncytium formation. Moreover, oral inoculation of SFE significantly improved RSV clearance from the lungs of BALB/c mice. Interestingly, the phenolic compounds eicosane, docosane, and tetracosane were identified as active components of SFE. Treatment with a non-cytotoxic concentration of these three components elicited similar antiviral effects against RSV infection as SFE in vitro. Together, these results suggest that SFE and its potential components are a promising natural antiviral agent candidate against RSV infection.

3 June 2026 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KKKasuni Karunarathne
Kasuni Karunarathne
SPSaumya Poorni
Saumya Poorni
NJNethra Jayampathi
Nethra Jayampathi
HDHasitha Dhananjaya
Hasitha Dhananjaya
AHAnju Hasintha
Anju Hasintha
LRLakmal Ranathunga
Lakmal Ranathunga
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune-evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signalling, thereby preventing the activation of antiviral defences. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of Tinospora cordifolia ’s bioactive compounds to disrupt B175L’s function and restore immune signalling. Gas chromatography-mass spectrometry (GC-MS) analysis of the methanol extract from T. cordifolia stems identified 86 compounds. These were filtered using SwissADME, ProTox 3.0, and DataWarrior, yielding 15 compounds with favourable drug-likeness and safety profiles. We generated a highly accurate 3D model of ASFV B175L with strong confidence scores for the structural accuracy, using AlphaFold3. The filtered compounds were then subjected to virtual screening with PyRx 0.8, and the 3 compounds with binding affinities ≤ −6 kcal/mol were selected for subsequent analysis. Molecular dynamics (MD) simulations were used to assess binding stability, including root mean square deviation and fluctuation (RMSD, RMSF), protein-ligand contacts, radius of gyration (rGyr), and solvent accessible surface area (SASA) using Schrödinger Maestro. Taken together, these in silico results suggest that T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl) hydrazone, Carbamic acid, N-(3-oxo-4-isoxazolidinyl)-, benzyl ester, and 1H-Indol-5-ol may act as potential inhibitors of B175L and represent preliminary antiviral hits against ASFV, warranting further in vitro and in vivo validation.

5 August 2025 in bioRxiv
Verified
Preprint
Open access
KKKasuni Karunarathne
Kasuni Karunarathne
SPSaumya Poorni
Saumya Poorni
NJNethra Jayampathi
Nethra Jayampathi
HDHasitha Dhananjaya
Hasitha Dhananjaya
AHAnju Hasintha
Anju Hasintha
LRLakmal Ranathunga
Lakmal Ranathunga
African swine fever virus (ASFV) is a highly lethal DNA virus that suppresses the host’s immune response by establishing infection. B175L, one of its key immune evasion proteins, directly inhibits STING-mediated type I interferon (IFN-I) signaling, preventing antiviral defense activation. Thus, targeting B175L could be a promising strategy for antiviral drug development as effective ASFV inhibitors remain unidentified. In this study, we investigated the potential of the Tinospora cordifolia plant’s bioactive compounds to disrupt B175L’s function, restoring immune signaling. Gas chromatography-mass spectrometry (GC-MS) analysis of T. cordifolia stem’s methanol extract identified 124 compounds, of which 52 met SwissADME and DataWarrior criteria for drug-likeness and safety. We generated a highly accurate 3D B175L model with strong confidence scores for the structure accuracy, utilizing AlphaFold3. Virtual screening was performed using PyRx 0.8, and the top 4 ligands with binding affinities exceeding -6 kcal/mol advanced to CB-Dock2 and UCSF Chimera. Among them, Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2pyridyl)hydrazone exhibited the highest binding affinity (-8.2 kcal/mol), confirming its strong interactions at the active site of B175L. Molecular dynamics (MD) simulations demonstrated the compound’s stability, with root mean square deviation and fluctuation (RMSD, RMSF) indicating minimal conformational changes (<2 Å). The compound maintained stable hydrogen bonds and hydrophobic interactions, reinforcing structural robustness. Taken together, these results clearly emphasize T. cordifolia- derived Benzaldehyde, 5-bromo-2-hydroxy-, (5-trifluoromethyl-2-pyridyl)hydrazone as a promising B175L inhibitor, advancing exploration towards effective antiviral solutions for ASFV.

20 April 2026 in Sri Lankan Journal of Infectious Diseases
Verified
Journal Article
Open access
MMM. J. B. Manathunga
M. J. B. Manathunga
LRLakmal Ranathunga
Lakmal Ranathunga
KKK. K. P. Karunarathne
K. K. P. Karunarathne
AAA. A. H. R. Adhikari
A. A. H. R. Adhikari
WWW. M. H. N. T. K. Wijekoon
W. M. H. N. T. K. Wijekoon
KSK. G. A. Samadhi
K. G. A. Samadhi